Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Clotrimazole 500mg pessary and Clotrimazole 2% cream
0702020F0AAAKAK
|
Clotrimazole (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 101,482 |
|
Clotrimazole 2% cream
0702020F0AAAJAJ
|
Clotrimazole (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 73,443 |
|
Clotrimazole 500mg pessaries
0702020F0AAAFAF
|
Clotrimazole (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 31,628 |
|
Clotrimazole 200mg pessaries
0702020F0AAAEAE
|
Clotrimazole (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 12,843 |
|
Fluconazole 150mg capsule and Clotrimazole 2% cream
0702020F0AAANAN
|
Clotrimazole (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 11,573 |
|
Clotrimazole 10% vaginal cream
0702020F0AAAGAG
|
Clotrimazole (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 5,877 |
|
Clotrimazole 100mg pessaries
0702020F0AAADAD
|
Clotrimazole (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 3,702 |
|
Clotrimazole 10% cream and Clotrimazole 2% cream
0702020F0AAALAL
|
Clotrimazole (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2,393 |
|
Fluconazole 150mg capsule and Clotrimazole 1% cream
0702020F0AAAPAP
|
Clotrimazole (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.